Talk:Novartis: Difference between revisions

Content deleted Content added

Inline

Revision as of 21:52, 19 September 2020

This is the talk page for discussing improvements to the Novartis article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Archives: 1: 2 months

Template:Vital article

This article has not yet been rated on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Companies Top‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany

Top This article has been rated as Top-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
High	This article has been rated as High-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Switzerland High‑importance

	Switzerland portal This article is within the scope of WikiProject Switzerland, a collaborative effort to improve the coverage of Switzerland on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SwitzerlandWikipedia:WikiProject SwitzerlandTemplate:WikiProject SwitzerlandSwitzerland
High	This article has been rated as High-importance on the project's importance scale.

The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.

Rusoke365 (talk · contribs) has been paid by Novartis on their behalf. Their editing has included contributions to this article.

2020 scandal: fake doctors lectures and more

Let us add this:

NOVARTIS violated the federal False Claims Act and Anti-Kickback Statute by providing doctors with cash payments, recreational outings, lavish meals, and expensive alcohol to induce them to prescribe NOVARTIS cardiovascular and diabetes drugs reimbursed by federal healthcare programs.  Specifically, the Government alleged that NOVARTIS organized tens of thousands of sham educational events at high-end restaurants and other venues, paid exorbitant speaker fees to doctors who gave no meaningful presentations, and provided expensive meals and alcohol to doctor attendees and their guests.  When those doctors then prescribed NOVARTIS’s cardiovascular and diabetes drugs, federal healthcare programs paid hundreds of millions of dollars in reimbursements for these tainted prescriptions.  As part of the settlement, approved today by U.S. District Judge Paul G. Gardephe, NOVARTIS will pay the United States and various States a total of $678 million.  NOVARTIS also made extensive factual admissions in the settlement and agreed to strict limitations on any future speaker programs, including reductions to the amount it may spend on such programs.

https://www.justice.gov/usao-sdny/pr/acting-manhattan-us-attorney-announces-678-million-settlement-fraud-lawsuit-against

From what I know it is systemic: they do it in also outside of the USA. I have no time to search other RS-es to back it up here, tho.

Zezen (talk) 04:30, 21 July 2020 (UTC)[reply]

Other sources here

John Cummings (talk) 18:41, 7 August 2020 (UTC)[reply]

@@ Line 2: / Line 2: @@
 {{Vital article|topic=Society|level=5|class=C}}
 {{WikiProjectBannerShell|1=
-{{WikiProject Companies|class=C|importance=Mid}}
+{{WikiProject Companies|class=C|importance=Top}}
 {{WikiProject Pharmacology|class=C|importance=high}}
 {{WikiProject Switzerland|class=C|importance=high}}